Madrigal Pharmaceuticals Inc (MDGL) Insider Trading
- $131,963,636.35
- $433,784,704.44
- March 6, 2026
- Bruce Kovner
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 6, 2026 | Insider | 419 | $431.94 | Sell | $180,982.86 | |
| March 6, 2026 | CEO | 1,663 | $431.94 | Sell | $718,316.22 | |
| March 6, 2026 | General Counsel | 360 | $431.94 | Sell | $155,498.40 | |
| March 6, 2026 | Director | 491 | $431.94 | Sell | $212,082.54 | |
| March 6, 2026 | CFO | 1,982 | $430.87 | Sell | $853,984.34 | |
| March 2, 2026 | CFO | 1,183 | $427.21 | Sell | $505,389.43 | |
| Sept. 9, 2025 | CEO | 7,279 | $445.63 | Sell | $3,243,740.77 | |
| Aug. 21, 2025 | CEO | 7,616 | $400.18 | Sell | $3,047,770.88 | |
| Aug. 20, 2025 | Director | 59,901 | $385.16 | Buy | $23,071,469.16 | |
| Aug. 18, 2025 | Director | 68,618 | $364.04 | Buy | $24,979,696.72 | |
| Aug. 18, 2025 | General Counsel | 1,304 | $367.81 | Sell | $479,624.24 | |
| Aug. 15, 2025 | Director | 10,000 | $365.20 | Sell | $3,652,000.00 | |
| Aug. 13, 2025 | Director | 129,172 | $370.24 | Sell | $47,824,641.28 | |
| Aug. 12, 2025 | Director | 43,605 | $355.68 | Sell | $15,509,426.40 | |
| Aug. 12, 2025 | Director | 43,263 | $355.69 | Sell | $15,388,216.47 | |
| Aug. 11, 2025 | Director | 3,203 | $350.27 | Sell | $1,121,914.81 | |
| Aug. 11, 2025 | Director | 3,200 | $350.24 | Sell | $1,120,768.00 | |
| July 18, 2025 | Director | 1,000 | $350.00 | Sell | $350,000.00 | |
| July 18, 2025 | Director | 1,400 | $350.03 | Sell | $490,042.00 | |
| July 17, 2025 | Director | 2,657 | $350.41 | Sell | $931,039.37 | |
| July 17, 2025 | Director | 2,700 | $350.48 | Sell | $946,296.00 | |
| July 16, 2025 | Director | 26,444 | $353.47 | Sell | $9,347,160.68 | |
| July 16, 2025 | Director | 26,176 | $353.47 | Sell | $9,252,430.72 | |
| March 5, 2025 | VP | 14,113 | $341.32 | Sell | $4,817,049.16 | |
| Feb. 28, 2025 | VP | 1,227 | $341.07 | Sell | $418,492.89 | |
| Feb. 27, 2025 | Director | 15,470 | $347.45 | Sell | $5,375,051.50 | |
| Jan. 24, 2025 | CMO | 648 | $335.24 | Sell | $217,235.52 | |
| Jan. 24, 2025 | Insider | 347 | $335.24 | Sell | $116,328.28 | |
| Jan. 24, 2025 | VP | 103 | $335.24 | Sell | $34,529.72 | |
| Jan. 24, 2025 | CEO | 1,584 | $335.24 | Sell | $531,020.16 | |
| Jan. 17, 2025 | CMO | 1,689 | $273.41 | Sell | $461,789.49 | |
| Jan. 17, 2025 | General Counsel | 277 | $273.41 | Sell | $75,734.57 | |
| Jan. 17, 2025 | VP | 442 | $273.41 | Sell | $120,847.22 | |
| Dec. 3, 2024 | Director | 3,600 | $315.31 | Sell | $1,135,116.00 | |
| Nov. 25, 2024 | Director | 3,400 | $350.30 | Sell | $1,191,020.00 | |
| Nov. 1, 2024 | Director | 5,000 | $300.94 | Sell | $1,504,700.00 | |
| Sept. 9, 2024 | CEO | 6,363 | $243.83 | Sell | $1,551,490.29 | |
| June 14, 2024 | VP | 1,900 | $280.00 | Sell | $532,000.00 | |
| June 12, 2024 | VP | 2,000 | $285.00 | Sell | $570,000.00 | |
| May 21, 2024 | VP | 1,036 | $231.34 | Sell | $239,668.24 | |
| May 14, 2024 | Director | 22,489 | $212.88 | Sell | $4,787,458.32 | |
| April 8, 2024 | CMO | 2,676 | $245.99 | Sell | $658,269.24 | |
| April 8, 2024 | Director | 26,270 | $246.19 | Sell | $6,467,411.30 | |
| April 5, 2024 | CMO | 27,506 | $243.36 | Sell | $6,693,860.16 | |
| April 4, 2024 | Director | 18,710 | $242.96 | Sell | $4,545,781.60 | |
| April 3, 2024 | CMO | 27,845 | $245.14 | Sell | $6,825,923.30 | |
| April 1, 2024 | Director | 11,000 | $257.48 | Sell | $2,832,280.00 | |
| Dec. 13, 2023 | VP | 2,500 | $225.40 | Sell | $563,500.00 | |
| Dec. 13, 2023 | Director | 81,159 | $219.39 | Buy | $17,805,473.01 | |
| Dec. 4, 2023 | SVP | 1,800 | $218.87 | Sell | $393,966.00 |
Insiders are both buying and selling Madrigal Pharmaceuticals Inc stock.
The insider traders at Madrigal Pharmaceuticals Inc are: Bruce Kovner, Rebecca Taub, Paul A Friedman, Robert E Waltermire, Bros. Advisors Lp Baker, Richard S Levy, William John Sibold, Fred B Craves, Safi R Bahcall, Bay City Capital Llc, Brian Joseph Lynch, Shannon T Kelley, Keith R Gollust, Mardi Dier, Carole Huntsman, Robert N Wilson, Kenneth Bate, James M Daly, Remy Sukhija, Safi Bahcall, Vojo Vukovic, and Marc R Schneebaum
The most active insider trader at Madrigal Pharmaceuticals Inc is Bruce Kovner with 16 trades.
Bay City Capital Llc has sold the most Madrigal Pharmaceuticals Inc stock with a total value of $210,009,114.84.
Bros. Advisors Lp Baker has bought the most Madrigal Pharmaceuticals Inc stock with a total value of $114,504,678.51.
The most recent insider trade for Madrigal Pharmaceuticals Inc was on March 6, 2026.
The single biggest insider buy for Madrigal Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $24,979,696.72 on Aug. 18, 2025.
The single biggest insider sell for Madrigal Pharmaceuticals Inc was from Bay City Capital Llc with a total value of $126,564,000.00 on Dec. 13, 2019.